XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products.

Source:http://linkedlifedata.com/resource/pubmed/id/19895808

Eur. J. Pharmacol. 2010 Feb 10 627 1-3 340-7

Download in:

View as

General Info

PMID
19895808